These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 20493936)

  • 41. Experimental Determination and Theoretical Calculation of the Eutectic Composition of Cefuroxime Axetil Diastereomers.
    Dalal N; Buckner IS; Wildfong PLD
    AAPS PharmSciTech; 2017 Oct; 18(7):2570-2578. PubMed ID: 28229357
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Nanonization of curcumin by antisolvent precipitation: process development, characterization, freeze drying and stability performance.
    Yadav D; Kumar N
    Int J Pharm; 2014 Dec; 477(1-2):564-77. PubMed ID: 25445971
    [TBL] [Abstract][Full Text] [Related]  

  • 43. In vitro characterization and invivo toxicity study of repaglinide loaded poly (methyl methacrylate) nanoparticles.
    Dhana Lekshmi UM; Poovi G; Kishore N; Reddy PN
    Int J Pharm; 2010 Aug; 396(1-2):194-203. PubMed ID: 20600729
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparison of different methods for preparation of a stable riccardin D formulation via nano-technology.
    Liu G; Zhang D; Jiao Y; Zheng D; Liu Y; Duan C; Jia L; Zhang Q; Lou H
    Int J Pharm; 2012 Jan; 422(1-2):516-22. PubMed ID: 22119965
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Preparation and characterization of betulin nanoparticles for oral hypoglycemic drug by antisolvent precipitation.
    Zhao X; Wang W; Zu Y; Zhang Y; Li Y; Sun W; Shan C; Ge Y
    Drug Deliv; 2014 Sep; 21(6):467-79. PubMed ID: 24479653
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Experimental investigation and oral bioavailability enhancement of nano-sized curcumin by using supercritical anti-solvent process.
    Anwar M; Ahmad I; Warsi MH; Mohapatra S; Ahmad N; Akhter S; Ali A; Ahmad FJ
    Eur J Pharm Biopharm; 2015 Oct; 96():162-72. PubMed ID: 26241925
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Studies on drug-polymer interaction, in vitro release and cytotoxicity from chitosan particles excipient.
    Gomathi T; Govindarajan C; Rose H R MH; Sudha PN; Imran PK; Venkatesan J; Kim SK
    Int J Pharm; 2014 Jul; 468(1-2):214-22. PubMed ID: 24742716
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Physicochemical properties of tadalafil solid dispersions - Impact of polymer on the apparent solubility and dissolution rate of tadalafil.
    Wlodarski K; Sawicki W; Haber K; Knapik J; Wojnarowska Z; Paluch M; Lepek P; Hawelek L; Tajber L
    Eur J Pharm Biopharm; 2015 Aug; 94():106-15. PubMed ID: 25998701
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Optimization, in-vitro Release and in-vivo Evaluation of Gliquidone Nanoparticles.
    Mohamed MS; Abdelhafez WA; Zayed G; Samy AM
    AAPS PharmSciTech; 2019 Dec; 21(2):35. PubMed ID: 31879830
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of the solid-dispersion method on the solubility and crystalline property of tacrolimus.
    Joe JH; Lee WM; Park YJ; Joe KH; Oh DH; Seo YG; Woo JS; Yong CS; Choi HG
    Int J Pharm; 2010 Aug; 395(1-2):161-6. PubMed ID: 20580799
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Preformulation studies for direct compression suitability of cefuroxime axetil and paracetamol: a graphical representation using SeDeM diagram.
    Singh I; Kumar P
    Acta Pol Pharm; 2012; 69(1):87-93. PubMed ID: 22574511
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Stabilization of low glass transition temperature indomethacin formulations: impact of polymer-type and its concentration.
    Chokshi RJ; Shah NH; Sandhu HK; Malick AW; Zia H
    J Pharm Sci; 2008 Jun; 97(6):2286-98. PubMed ID: 17879977
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Simultaneous micronization and surface modification for improvement of flow and dissolution of drug particles.
    Han X; Ghoroi C; To D; Chen Y; Davé R
    Int J Pharm; 2011 Aug; 415(1-2):185-95. PubMed ID: 21664954
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Preparation of osthole-polymer solid dispersions by hot-melt extrusion for dissolution and bioavailability enhancement.
    Yun F; Kang A; Shan J; Zhao X; Bi X; Li J; Di L
    Int J Pharm; 2014 Apr; 465(1-2):436-43. PubMed ID: 24576810
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Preparation, physicochemical characterization, and antioxidant effects of quercetin nanoparticles.
    Wu TH; Yen FL; Lin LT; Tsai TR; Lin CC; Cham TM
    Int J Pharm; 2008 Jan; 346(1-2):160-8. PubMed ID: 17689897
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Preparation of a chemically stable quercetin formulation using nanosuspension technology.
    Gao L; Liu G; Wang X; Liu F; Xu Y; Ma J
    Int J Pharm; 2011 Feb; 404(1-2):231-7. PubMed ID: 21093559
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Modified supercritical antisolvent method with enhanced mass transfer to fabricate drug nanoparticles.
    Kakran M; Sahoo NG; Antipina MN; Li L
    Mater Sci Eng C Mater Biol Appl; 2013 Jul; 33(5):2864-70. PubMed ID: 23623107
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A continuous and highly effective static mixing process for antisolvent precipitation of nanoparticles of poorly water-soluble drugs.
    Dong Y; Ng WK; Hu J; Shen S; Tan RB
    Int J Pharm; 2010 Feb; 386(1-2):256-61. PubMed ID: 19922777
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Molecular simulation of hydroxypropyl-beta-cyclodextrin with hydrophobic selective Cox-II chemopreventive agent using host-guest phenomena.
    Sinha VR; Nanda A; Chadha R; Goel H
    Acta Pol Pharm; 2011; 68(4):585-92. PubMed ID: 21796941
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Preparation and characterization of nanocrystals for solubility and dissolution rate enhancement of nifedipine.
    Hecq J; Deleers M; Fanara D; Vranckx H; Amighi K
    Int J Pharm; 2005 Aug; 299(1-2):167-77. PubMed ID: 15996838
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.